The catastrophic antiphospholipid (Asherson's) syndrome and malignancies

Autoimmunity Reviews

Volumn 6, Issue 2, 2006, Pages 94-97

  Miesbach, W ^a   Asherson, R A ^b   Cervera, R ^c   Shoenfeld, Y ^d   Puerta, J Gomez ^c   Bucciarelli, S ^c   Espinoza, G ^c   Font, J ^c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c HOSPITAL CLÍNIC   (Spain)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anticoagulation; Catastrophic antiphospholipid syndrome; Leukaemia; Malignancy; Surgery; Thrombosis

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIPHOSPHOLIPID SYNDROME; BRAIN DISEASE; BRAIN INFARCTION; CANCER; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; COLON CARCINOMA; CONVALESCENCE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CARCINOMA; REGISTER; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TERMINAL DISEASE;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS;

EID: 33751338274     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.06.012     Document Type: Review

References (19)

1. Asherson R.A. Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun 15 (2000) 117-122
2. Bessis D., Sotto A., Viaid J.P., Berard M., Civana A.J., and Boffa M. Trousseau's syndrome with non-bacterial thrombotic endocarditis: pathogenetic role of antiphospholipid syndrome. Am J Med 98 (1995) 511-513
3. Faiderbe S., Chagnaud J.L., Charrier M.C., Peyron M.A., Wafflart J., Geffard M., et al. Antibodies directed against lipid membrane components in sera of patients with malignant tumours. Cancer Detec Prev 15 (1991) 199-203
4. Genvresse I., Buttgereit F., Späth-Schwalbe E., Ziemer S., Eucker J., and Possinger K. Arterial thrombosis associated with anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases. Eur J Haematol 65 (2000) 344-347
5. Liozon E., Loustaud V., Jauberteau M.O., Jaccard A., Soria P., Bordessoule D., et al. Non-simultaneous malignant lymphoma and antiphospholipid syndrome: 4 cases. Rev Med Interne 22 (2001) 360-370
6. Lossos I.S., Bogomolski-Yahalom V., and Hatzner Y. Anticardiolipin antibodies in acute myeloid leukaemia: prevalence and clinical significance. Am J Hematol 57 (1998) 139-143
7. McNeil H.P., Chesterman C.N., and Krilis S.A. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49 (1991) 193-280
8. Miesbach W., Scharrer I., and Asherson R.A. Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 25 (2006) 1-5
9. Piette J.-C., Cervera R., Levy R.A., Nasonov E.L., Triplett D.A., and Shoenfeld Y. The Catastrophic Antiphospholipid Syndrome-Asherson's Syndrome. Ann Med Interne 154 (2000) 195-196
10. Schved J.F., Dupuy-Fons C., Biron C., Quere I., and Janbon C. A prospective epdimiological study of the occurrence of antiphospholipid antibody; the Montpelier Antiphospholipid (MAP) Study. Haemostasis 24 (1994) 175-182
11. Stasi R., Stipa E., Masi M., Oliva F., Sciarra A., Perrotti A., et al. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost 70 (1993) 568-572
12. Yoon K.H., Wong A., Shakespeare T., and Sivalingham P. High prevalence of the antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12 (2003) 112-116
13. Zuckerman E., Toubi E., Golan T., Rosenvald-Zuckerman T., Sabo E., Shmuel Z., et al. Increased thromboembolic incidence in anticardiolipin-positive patients with malignancy. Br J Cancer 72 (1995) 447-451
14. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 1-23
15. Yamamoto T., Ito M., Nagata S., Suzuki H., Togawa A., Nagase M., et al. Catastrophical exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol 27 (2000) 2035-2037
16. Soltesz P., Szekanecz Z., Vegh J., Lakos G., Toth L., Szakall S., et al. Catastrophic antiphospholipid syndrome in cancer. Haematologica 30 (2000) 303-311
17. Campbell A.L., Pierangeli S.S., Wellhausen S., and Harris E.N. Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 73 (1995) 529-534
18. Meroni P.L., Raschi E., Camera M., Testoni C., Nicoletti F., and Tincani A. Endothelial activation by aPL. A potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 15 (2000) 237-240
19. Dobado-Berrios P.M., Lopez-Pedreda C., Velazco F., and Cuadrado M.J. The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum 44 (2001) 2467-2476